News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
65,300 Results
Type
Article (6754)
Company Profile (18)
Press Release (58528)
Section
Business (16977)
Career Advice (83)
Deals (2787)
Drug Delivery (9)
Drug Development (14852)
Employer Resources (16)
FDA (2002)
Job Trends (2402)
News (35741)
Policy (5339)
Tag
Academia (399)
Africa (170)
Alabama (9)
Alliances (5560)
Alzheimer's disease (157)
Approvals (2005)
Asia (4468)
Australia (711)
Bankruptcy (25)
Best Places to Work (2152)
Biotechnology (10)
C2C Services and Suppliers (1619)
California (190)
Canada (107)
Cancer (88)
Career advice (79)
Cell therapy (22)
China (11)
Clinical research (10378)
Collaboration (34)
Connecticut (10)
COVID-19 (2009)
Cystic fibrosis (9)
Data (79)
Delaware (9)
Diagnostics (391)
Drug discovery (7)
Earnings (5636)
Employer resources (14)
Europe (10969)
Events (8054)
Executive appointments (16)
FDA (2065)
Florida (25)
Funding (20)
Gene therapy (20)
Georgia (11)
GLP-1 (68)
Government (1817)
Healthcare (2222)
Hotbed/Location (40423)
Illinois (13)
Indiana (17)
Infectious disease (2047)
Inflammatory bowel disease (21)
Influenza (11)
Interviews (8)
IPO (1192)
Job creations (320)
Job search strategy (75)
Kansas (8)
Layoffs (71)
Legal (521)
Lung cancer (11)
Management (9)
Manufacturing (21)
Maryland (182)
Massachusetts (180)
Medical device (432)
Medtech (432)
Mergers & acquisitions (1595)
Metabolic disorders (18)
Minnesota (10)
Montana (8)
Multiple sclerosis (9)
Neuroscience (178)
New Jersey (150)
New York (85)
NextGen Class of 2024 (411)
Non-profit (362)
North Carolina (52)
Northern California (105)
Obesity (9)
Opinion (35)
Ovarian cancer (8)
Patents (14)
Pennsylvania (87)
People (4658)
Phase I (3728)
Phase II (4489)
Phase III (3625)
Pipeline (24)
Postmarket research (425)
Preclinical (1606)
Press Release (20)
Radiopharmaceuticals (14)
Rare diseases (19)
Real estate (510)
Regulatory (3345)
Reports (11)
Research institute (411)
RSV (23)
South America (112)
Southern California (75)
Startups (323)
Texas (21)
United States (1106)
Vaccines (588)
Washington State (23)
Weight loss (11)
Date
Today (6)
Last 7 days (73)
Last 30 days (326)
Last 365 days (4135)
2024 (3095)
2023 (4541)
2022 (7866)
2021 (8864)
2020 (7241)
2019 (3443)
2018 (2591)
2017 (2680)
2016 (2544)
2015 (3091)
2014 (2271)
2013 (1806)
2012 (2044)
2011 (2220)
2010 (2018)
65,300 Results for "rational vaccines".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Rational Vaccines and Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Announce Collaboration to Develop Herpes Vaccines in China
Rational Vaccines and Shenzhen Mellow Hope Pharm Industrial Co., Ltd. announced they have reached an agreement to jointly develop, manufacture, and commercialize live vaccines against herpes simplex viruses.
October 30, 2023
·
2 min read
Vaccines
5 Late-Stage mRNA Vaccines to Watch
The potential of mRNA vaccines was established during the COVID-19 pandemic. Now, a new wave of candidates could soon hit the market for cancer, influenza and more.
September 16, 2024
·
5 min read
·
Ben Hargreaves
Rational’s Experimental Herpes Vaccine Shows Preclinical Promise
Rational Vaccines said findings from a pilot study showed that RVX201 led to a reduction in recurrent genital lesions when compared to gD2-alum/MPL vaccine in animal studies.
July 8, 2022
·
2 min read
·
Alex Keown
BioMidwest
FDA Accepts Professor Niazi’s Petition to Allow Interchangeable Status to Biosimilars without Additional Clinical Testing--A rational step towards removing misconceptions about biosimilars
According to Pharmaceutical Scientist, Inc., biosimilars are copies of biological drugs introduced after the expiry of the patents or exclusivity of new biological drugs as a more affordable choice for patients.
June 24, 2024
·
4 min read
Infectious disease
Bavarian Nordic Accelerates Mpox Vaccine Production to Respond to Global Emergency
The Danish company on Saturday announced plans to increase production of its vaccine Jynneos on the heels of the World Health Organization last week declaring mpox a global health emergency.
August 19, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Meningococcal Vaccines Market to Reach USD 7.2 Billion by 2032, Impelled by the Increasing Prevalence of Meningococcal Disease
Meningococcal Vaccines Market Report 2024-2032:
August 8, 2024
·
16 min read
Infectious disease
GSK Abandons Herpes Vaccine After Disappointing Phase I/II Proof-of-Concept Data
Without revealing specific details, GSK announced that it is terminating the development of its investigational herpes simplex virus vaccine after failing to meet the study’s primary efficacy objective.
September 11, 2024
·
2 min read
·
Tristan Manalac
Business
Novavax Misses Q2 Revenue Estimate, Cuts 2024 Forecast on COVID-19 Vaccine Sales
The vaccine maker on Thursday reported $415.5 million in total revenue in the second quarter, lower than the analyst consensus of $458.6 million.
August 8, 2024
·
1 min read
·
Kate Goodwin
Pharm Country
Tonix Pharmaceuticals Presents Vaccine Platform Data in Keynote Talk at the Vaccine Congress 2024
Tonix Pharmaceuticals Holding Corp. today announced data presented at an oral Keynote Talk at the Vaccine Congress 2024 held June 24-25, 2024 in Prague, Czech Republic.
June 25, 2024
·
8 min read
Vaccines
RSV Vaccine Makers Hit Hard by New CDC Guidelines
GSK, Moderna and Pfizer are all looking at potential respiratory syncytial virus vaccine sales slumps thanks to recently updated CDC guidelines regarding the use of RSV shots in seniors.
August 2, 2024
·
3 min read
·
Greg Slabodkin
1 of 6,530
Next
